NCT00206739 Intermittent Treatment With Sulfadoxine-pyrimethamine for Malaria Control in Infants Status COMPLETED Phase PHASE4
NCT00204334 Effects of Anemia Correction on Vascular and Monocyte Function in Renal Transplant Recipients Status COMPLETED Phase PHASE4
NCT00198835 Evaluation Research of the Nutrition Interventions in the INHP II Areas of CARE India Status COMPLETED Phase NA
NCT00194857 Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and Ribavirin Status TERMINATED Phase PHASE4
NCT00189371 Reinduction Chemotherapy Containing Carboplatin and Paclitaxel With or Without Epoetin Alpha in Recurrent Platinum Sensitive Ovarian Cancer, Cancer of the Fallopian Tube or Peritoneum Status TERMINATED Phase PHASE3
NCT00173706 Evaluation of the Effects of L-Carnitine Injection in Patients Undergoing Hemodialysis Status UNKNOWN Phase PHASE4
NCT00168948 Intermittent Antimalaria Treatment With SP in African Children Status UNKNOWN Phase PHASE4
NCT00153868 A Web-based Study of Quality of Life Benefits Associated Aranesp in Anemic Patients With Cancer Status COMPLETED Phase PHASE4
NCT00148629 Treatment and Prevention of Severe Anemia in Pregnant Zanzibari Women Status COMPLETED Phase PHASE3
NCT00148421 Study for the Treatment of Anemia in Patients With Non-myeloid Malignancies Receiving Multicycle Chemotherapy. Status COMPLETED Phase PHASE3
NCT00145652 Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders. Status COMPLETED Phase PHASE3
NCT00144131 Flexibility: A Study to Assess the Impact of Darbepoetin Alfa in Subjects withNon-Myeloid Malignancies With Anemia Due to Chemotherapy Status COMPLETED Phase PHASE2
NCT00126334 Conservative Versus Liberal Red Cell Transfusion in Myocardial Infarction Trial: The CRIT Pilot Status COMPLETED Phase PHASE4
NCT00123149 Open-Label Extension Safety Study of PROCRIT in Patients With Anemia of Chronic Disease Due to Rheumatoid Arthritis Status WITHDRAWN Phase PHASE2
NCT00121602 Efficacy Study: Darbepoetin Alfa for the Treatment of Anemia in Patients With Chronic Kidney Disease Status COMPLETED Phase PHASE3